Boundless persevered with the other drug, a CHK1 inhibitor BBI-355, as a monotherapy for oncogene-amplified solid tumors. But the clinical data showed signs of hematological toxicity that would have ...
BBI-940 IND accepted; initiation of first-in-human clinical trial on track for the first half of 2026Portfolio prioritization, including ...
Boundless Bio, a clinical-stage oncology company, announced its financial results for the first quarter of 2025, highlighting its ongoing commitments to developing innovative therapies for patients ...
2025 is shaping up to be a big year for BBI Brands. The entire family of BBI Brands – including BBI Transportation and BBI Real Estate – is almost completely moved into the new office space at Astor ...
FORT LAUDERDALE, Fla., Nov. 4, 2025 /PRNewswire/ -- Burdette Beckmann Inc. (BBI), a national sales agency leader in the confectionery industry, is proud to announce the acquisition of Action Sales ...
This acquisition marks gWorks’ eighth in a decade and fifth since partnering with BV Investment Partners in 2022 Moneesh Arora serves as CEO of gWorks and Barbara Bishop serves as CEO of BBI Inc BBI, ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min BBI Logistics is a ...
MCKINNEY, Texas--(BUSINESS WIRE)--ScienceSoft released proprietary research exploring the potential of behavior-based insurance (BBI) in life and health plans. Supported by statistical sources, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results